Abstract:Cefdinir is a broad-spectrum antibiotic with good antibacterial activity against gram-positive and gram-negative bacteria and can be used for the treatment of various sensitive bacterial infections, such as community-acquired pneumonia, urinary tract infection and gonorrhoea. Herein, a single-centred, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, double-crossover trial with a 7-day washout was conducted to investigate the pharmacokinetics, bioequivalence and safety of cefdinir dispersible tablets and the reference formulation of cefdinir capsules in healthy Chinese volunteers. Fifty-six healthy subjects were recruited and randomly assigned to the fasting and fed groups. After a single oral dose of the test or reference formulation (0.1 g), the cefdinir concentrations in the plasma were determined via HPLC–MS/MS, and pharmacokinetic parameters were obtained from the concentration‒time profiles. Overall, 24 and 31 individuals completed the evaluation under fasting and fed conditions respectively. The mean concentration‒time profiles for both formulations were similar, and the C max , AUC 0– t and AUC 0–∞ values were entirely within the bioequivalence range of 80.00% to 125.00%. Three subjects reported 5 AEs, and 8 subjects experienced 13 AEs in the fasting and fed groups respectively, but no participants withdrew from the trial because of AEs. All adverse reactions were grade I in severity, and no serious AEs or deaths occurred. The results demonstrated that these formulations were bioequivalent in healthy Chinese subjects under fasting and fed conditions, supporting the further clinical development of cefdinir dispersible tablets. This trial was registered in the China Drug Trials Registry (registration number: CTR20210441; registration date: March 11, 2021).

Pharmacokinetics and Bioequivalence of Cefdinir Dispersible Tablet in Healthy Volunteers

Bioequivalence of cefdinir dispersible tablets in healthy Chinese subjects under fasting and fed conditions: a single-centred, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, double-crossover trial

Pharmacokinetics and Bioequivalence Study of Cefdinir Suspension in Healthy Volunteers

Pharmacokinetic and Bioequivalence Evaluation of Two Cefprozil Dispersible Tablets in Healthy Chinese Volunteers

Pharmacokinetics and relative bioavailability of domestic vs imported cefpodoxime proxetil tablets in human body

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Pharmacokinetics and bioequivalance of cefetamet pivoxil dispersible tablets in healthy volunteers

Pharmacokinetics and Bioequivalance of Clarithromycin Dispersed Tablet in Healthy Volunteers

The Bioequivalence of Cefpodoxime Oral Suspension in Healthy Volunteers

Study on Pharmacokinetics and Bioequivalence of Azithromycin Dispersible Tablets in Healthy Volunteers

Study of the Pharmacokinetics and Bioequivalence of Gatifloxacin Dispersible Tablets in Chinese Healthy Volunteers

Relative bioavailability of cefpodoxime proxetil tablets in healthy volunteers

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioequivalence of 2 Kinds of Cefadroxil Tablets in Healthy Subjects

Bioequivalence of erythromycin ethylsuccinate orally disintegrating tablet in healthy volunteers

Bioequivalence of domestic and imported Cefdinir Granule in healthy volunteers

Pharmacokinetics and Bioequivalence of 2 Kinds of Amoxicillin Dispersible Tablets in Healthy Volunteers

Bioavailability of Cefuroxime Axetii Suspension in Healthy Volunteers

A Study of the Bioequivalence of Fleroxacin Tablets in Healthy Chinese Volunteers

Relative Bioavailability of Cefadroxil in Healthy Volunteers